BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25678220)

  • 1. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
    Young K; Fidelman N; Yao FY; Hills NK; Kohi MP; Kolli KP; Taylor AG; Kerlan RK
    Liver Transpl; 2015 Apr; 21(4):454-67. PubMed ID: 25678220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
    Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
    Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
    Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
    Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
    J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
    Song KD; Rhim H; Lee MW; Kim YS; Kang TW
    Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.
    Ladd LM; Tirkes T; Tann M; Agarwal DM; Johnson MS; Tahir B; Sandrasegaran K
    Clin Mol Hepatol; 2016 Dec; 22(4):450-457. PubMed ID: 27987537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary nodules in liver transplant candidates with hepatocellular carcinoma: Imaging characteristics and clinical outcomes.
    Lee C; Ihde L; Kim A; Santos I; Matsuoka L; Cen Y; Wallman M; Grant E
    Liver Transpl; 2015 Sep; 21(9):1169-78. PubMed ID: 25845578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
    Kim AY; Sinn DH; Jeong WK; Kim YK; Kang TW; Ha SY; Park CK; Choi GS; Kim JM; Kwon CHD; Joh JW; Kim MJ; Sohn I; Jung SH; Paik SW; Lee WJ
    J Hepatol; 2018 Jun; 68(6):1144-1152. PubMed ID: 29410377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
    J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.
    Burrel M; Llovet JM; Ayuso C; Iglesias C; Sala M; Miquel R; Caralt T; Ayuso JR; Solé M; Sanchez M; Brú C; Bruix J;
    Hepatology; 2003 Oct; 38(4):1034-42. PubMed ID: 14512891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.
    Yim SY; Park BJ; Um SH; Han NY; Sung DJ; Cho SB; Lee SH; Kim MJ; Jung JY; Kim JD; Seo YS; Kim DS; An H; Kim YH
    Medicine (Baltimore); 2016 Sep; 95(39):e4903. PubMed ID: 27684824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm.
    Kim SR; Ando K; Mita K; Fuki S; Ikawa H; Kanbara Y; Imoto S; Matsuoka T; Hayashi Y; Kudo M
    Oncology; 2007; 72 Suppl 1():58-66. PubMed ID: 18087183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.
    Ogasawara S; Chiba T; Motoyama T; Kanogawa N; Saito T; Shinozaki Y; Suzuki E; Ooka Y; Tawada A; Kato H; Okabe S; Kanai F; Yoshikawa M; Yokosuka O
    PLoS One; 2016; 11(9):e0163119. PubMed ID: 27649084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.